- Home
- DCOY vs CNSP Comparison
DCOY vs CNSP Comparison
Compare DCOY & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DCOY | CNSP |
|---|---|---|
| Founded | N/A | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7M | 3.8M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | DCOY | CNSP |
|---|---|---|
| Price | $0.72 | $3.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 159.3K | 18.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.62 | $0.73 |
| 52 Week High | $1.41 | $10.59 |
Technical Indicators
Market Signals| Indicator | DCOY | CNSP |
|---|---|---|
| Relative Strength Index (RSI) | 45.50 | 22.95 |
| Support Level | $0.65 | $0.86 |
| Resistance Level | $0.85 | $8.89 |
| Average True Range (ATR) | 0.07 | 0.32 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 13.89 | 8.93 |
Price Performance
Historical ComparisonAbout DCOY Decoy Therapeutics Inc. Common Stock
Decoy Therapeutics Inc is a preclinical-stage biotechnology company developing peptide conjugate drug candidates using machine learning, artificial intelligence tools, and high-throughput synthesis techniques. The company's initial pipeline is focused on respiratory viruses and GI cancers.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.